All about Omi­cron; We need more Covid an­tivi­rals; GSK snags Pfiz­er’s vac­cine ex­ec; Janet Wood­cock’s fu­ture at FDA; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

The slate of prod­ucts we’re of­fer­ing here at End­points is con­tin­u­ing to grow, and it’s not just lim­it­ed to ed­i­to­r­i­al. If you haven’t, do vis­it your read­er pro­file to see if there are any oth­er week­ly newslet­ters you’re in­ter­est­ed in — as each comes with its own ex­clu­sive con­tent. And don’t miss the pub­lish­er’s note from Ar­salan Arif on End­points Stu­dio, our lat­est av­enue for ad­ver­tis­ing on End­points.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.